gs2-09: "tamoxifen instigates uterine cancer development by activating pi3k signaling and..."
Published 1 year ago • 294 plays • Length 10:24Download video MP4
Download video MP3
Similar videos
-
8:11
san antonio breast cancer symposium 2008: big 1-98: letrozole vs tamoxifen
-
17:34
gs2 03. discussant
-
3:04
breast cancer treatment and risk of developing uterine cancer - dr. david margileth
-
15:33
gs2-10: "nimbus: a phase 2 trial of nivolumab plus ipilimumab for patients with hypermutated..."
-
12:11
gs2-08: discussant
-
13:53
gs2-01: "overall survival subgroup analysis by metastatic site from the phase3 monaleesa-2..."
-
2:41
uterine cancer & prevention episode 2 - what is the best way to fight uterine cancer?
-
12:44
gs3-03: "genomic analysis of 733 her2 breast cancers identifies recurrent pathways alterations..."
-
10:05
gs2-05: "randomized comparison of adjuvant aromatase inhibitor exemestane (e) plus ovarian..."
-
0:56
the san antonio breast cancer symposium (sabcs) 2022
-
3:29
uterine cancer: causes, symptoms, diagnosis, and treatment
-
1:11
the mimosa trial and a novel prognostic factor in breast cancer
-
21:00
gs4 10 neratinib fulvestrant trastuzumab for hormone receptor-positive, her2-mutant metastatic
-
10:39
gs2-04: "aromatase inhibitors versus tamoxifen in pre-menopausal women with estrogen receptor..."
-
19:27
gs4 08 omprehensive genomic profiling of patients with breast cancer identifies germline-somatic
-
32:04
educational sessions: "management of special subtypes of tnbc"
-
17:55
translational science forum: "heterogeneity in treatment outcomes for her2 breast cancer clinic..."